Chondrosarcomas Completed Phase 2 Trials for Dasatinib (DB01254)

Also known as: Chondrosarcoma / Chondroma sarcomatosum / Chondrosarcoma NOS / [M]Chondrosarcoma NOS

IndicationStatusPhase
DBCOND0036125 (Chondrosarcomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00464620Trial of Dasatinib in Advanced SarcomasTreatment